Find clinical trials for Lymphoma in New York, NY
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lymphoma trials near New York, NY, USA:
glofitamab and obinutuzumab is in treating patients with Follicular Lymphoma (FL) and Marginal Zone Lymphoma (MZL) who have not rec...
Phase 2
New York, New York, United States and 3 other locations
of MT-601 administration to patients with Relapsed or Refractory Lymphoma. The starting dose administered is 200 x 10\^6 cells (flat dosing)....
Phase 1
New York, New York, United States and 6 other locations
is in treating participants with relapse or refractory Follicular Lymphoma (FL) or marginal zone lymphoma (MZL).* The names of the ...
Phase 2
New York, New York, United States and 1 other location
chimeric antigen receptor (CAR) targeting cluster of differentiation (CD)19 and CD20 in participants with aggressive large B-cell lymphoma....
Phase 1, Phase 2
Bronx, New York, United States and 16 other locations
DS-3201b is an experimental drug that is being investigated in clinical research.Adults with non-Hodgkin lymphoma (NHL) may be able to join ...
Phase 1
New York, New York, United States and 20 other locations
patients diagnosed with advanced Relapsed/Refractory non-Hodgkin's lymphoma to determine if ARV-393 may be a possible treatment option.ARV-3...
Phase 1
New York, New York, United States and 16 other locations
combination with mosunetuzumab injections for people with follicular lymphoma who haven't received treatment before. The investigators hypot...
Phase 2
New York, New York, United States
The purpose of this study is to evaluate the safety, tolerability, and preliminary efficacy of CC-99282 alone and in combination with anti-lymphoma...
Phase 1, Phase 2
Hackensack, New Jersey, United States and 68 other locations
Of Care in adult patients with aggressive B-cell Non-Hodgkin Lymphoma after failure of rituximab and anthracycline containing frontline immu...
Phase 3
Hackensack, New Jersey, United States and 71 other locations
The researchers are doing this study to find out whether the combination of epcoritamab with tafasitamab and lenalidomide is a safe and effective tre...
Phase 2
New York, New York, United States and 6 other locations
Clinical trials
Research sites
Resources
Legal